|
Real-time
Boerse Muenchen
15:18:20 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 61.01 EUR | -3.57% |
|
-12.00% | +21.67% |
| 10-07 | Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug | DJ |
| 10-07 | Tempus Expands Moderna, Merck Collaboration for Individualized Cancer Therapy | MT |
Company Valuation: Tempus AI, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 5,315 | 10,505 | 12,694 | - | - |
| Change | - | 97.64% | 20.83% | - | - |
| Enterprise Value (EV) 1 | 5,302 | 10,990 | 13,292 | 13,190 | 12,968 |
| Change | - | 107.29% | 20.94% | -0.77% | -1.68% |
| P/E | -5.42x | -41.9x | -50.5x | -53.9x | -110x |
| PBR | 94.1x | 20.8x | 25.3x | 22x | 16.8x |
| PEG | - | 0.5x | 39.41x | 8.62x | 2.2x |
| Capitalization / Revenue | 7.67x | 8.26x | 7.96x | 6.45x | 5.37x |
| EV / Revenue | 7.65x | 8.64x | 8.33x | 6.71x | 5.49x |
| EV / EBITDA | -50.6x | -1,488x | 204x | 88.2x | 44.9x |
| EV / EBIT | -37.3x | -233x | -1,536x | 240x | 66x |
| EV / FCF | -25.1x | -46x | -1,108x | 528x | 123x |
| FCF Yield | -3.98% | -2.18% | -0.09% | 0.19% | 0.81% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -6.23 | -1.41 | -1.392 | -1.305 | -0.6399 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 693.4 | 1,272 | 1,595 | 1,967 | 2,363 |
| EBITDA 1 | -104.7 | -7.385 | 65.26 | 149.5 | 288.7 |
| EBIT 1 | -142 | -47.19 | -8.654 | 54.89 | 196.3 |
| Net income 1 | -746.3 | -245 | -245.9 | -236.3 | -116.5 |
| Net Debt 1 | -13.71 | 484.5 | 598.1 | 496.3 | 274.4 |
| Reference price 2 | 33.76 | 59.05 | 70.35 | 70.35 | 70.35 |
| Nbr of stocks (in thousands) | 157,446 | 177,907 | 180,435 | - | - |
| Announcement Date | 2/24/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.73x | 7.76x | 15.59x | 1.37% | 74.68B | |
| 30.5x | 8.78x | 27.34x | 0.04% | 58.7B | |
| 33.66x | 6.05x | 18.11x | 0.96% | 48.36B | |
| -20.81x | 215.3x | -22.29x | -.--% | 43.05B | |
| 33.24x | 3.23x | 13.97x | -.--% | 42.48B | |
| 48.26x | 5.5x | 30.21x | -.--% | 41.39B | |
| 27.77x | 7.89x | 20.51x | 0.41% | 31.29B | |
| -14.93x | 5.54x | -6.96x | -.--% | 23.93B | |
| -61.76x | 11.97x | -60.92x | -.--% | 22.22B | |
| Average | 10.85x | 30.22x | 3.95x | 0.31% | 42.9B | |
| Weighted average by Cap. | 17.34x | 30.22x | 9.46x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- TEM Stock
- F3M Stock
- Valuation Tempus AI, Inc.
Select your edition
All financial news and data tailored to specific country editions
